2024 Annual Meeting | C127 - Neuro-oncology: Navigating Current Trends

Date Tuesday 04/16/24

Time 01:00 PM - 03:00 PM MDT Add To Calendar

Location Colorado Convention Center | 207

Session Format This program will be presented both in-person and online

On Demand This program will be available in the meeting's On Demand product.

Event Type Seminar

Director(s) Wendy Sherman, MD

Topic(s) Neuro-oncology

Learning Objectives Participants should increase their knowledge regarding key clinical trial evidence supporting advancements in the treatment of primary and secondary central nervous system tumors, and integrate emerging evidence into treatment paradigms for patients with primary and secondary central nervous system tumors.

CME Available 2.00 CME credits

Core Competencies Patient Care & Procedural Skills, Medical Knowledge, Practice-based Learning and Improvement

Program Level Advanced

Recommended Audience Fellow, Resident, General Neurologist, Specialist Neurologist, Advanced Practice Provider, Neurohospitalist, Medical Student

Teaching Styles Case-based, Didactic

Program Materials Program Evaluations

Event Timeline
01:00 PM - 01:40 PM MDT	Speaker	Updates in Management of IDH Mutated Astrocytoma Ugur Sener, MD
01:40 PM - 02:20 PM MDT	Speaker	Updates in Management of Glioblastoma Lauren Schaff, MD
02:20 PM - 03:00 PM MDT	Speaker	Update in the Management of Metastatic Disease for the CNS Wendy Sherman, MD

Faculty Disclosures
Wendy Sherman, MD	Dr. Sherman has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Focused ultrasound foundation . Dr. Sherman has received personal compensation in the range of $500-$4,999 for serving as a Advisory Board Member with Kiyatec.
Ugur Sener, MD	Dr. Sener has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Servier Pharmaceuticals.
Lauren Schaff, MD	Dr. Schaff has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Guidepoint. Dr. Schaff has received personal compensation in the range of $500-$4,999 for serving as a Consultant for ONO. Dr. Schaff has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for BTG Pharmaceuticals. Dr. Schaff has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Servier. An immediate family member of Dr. Schaff has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for MichieHamlett Attorneys at Law. The institution of Dr. Schaff has received research support from BTG, plc. The institution of Dr. Schaff has received research support from Merck. The institution of Dr. Schaff has received research support from DebioPharm.